Cargando…
Delayed immune-mediated hepatitis after three cycles of pembrolizumab for the treatment of sinonasal melanoma
Immune checkpoint inhibitors (ICIs) are monoclonal antibodies that induce the anti-tumor effects of T cells by targeting co-inhibitory immune checkpoints. The development of ICIs has revolutionized the clinical practice of oncology, leading to significant improvements in outcomes; therefore, ICIs ar...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394523/ https://www.ncbi.nlm.nih.gov/pubmed/37376755 http://dx.doi.org/10.4103/jpgm.jpgm_834_22 |